Eris Lifesciences forays into sanitizer business

Our Bureau Ahmedabad | Updated on May 21, 2020 Published on May 21, 2020

Launches 'TruSaniz' brand under its OTC product portfolio

Ahmedabad-based pharma player Eris Lifesciences announced its foray into sanitizer business through its fully-owned subsidiary Eris Healthcare Pvt Ltd, under the brand name TruSaniz.

The newly launched hand sanitizer is a part of the OTC product portfolio, which was envisaged earlier this year, a company statement said.

With the rising number of Covid-19 cases, there is a greater need for maintaining personal hygiene and sanitation, along with building immunity, even more for the people with comorbidities, with reports that indicate higher mortality rates amongst these patients, the statement said.

The company has roped in Bollywood actress Shilpa Shetty Kundra for brand promotion.

Amit Bakshi, Chairman and Managing Director, Eris Lifesciences said, “While control and management form an important aspect in building a strong healthcare system, disease prevention is equally important to strengthen pro-activity, and thus our range of products in this category will be helpful in combating diseases better. It will also help us expand our representation in the acute market."

Launched in two variants, liquid and spray, it is packaged in 100 ml costing ₹50, while the 250 ml bottle for ₹125 and 500ml for ₹249 for the liquid variant, whereas the spray is available for ₹179 for a bottle of 170 gm.

Eris Lifesciences shares gained 2.4 per cent on Thursday to close at Rs 487 on BSE.

Published on May 21, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.